vs
Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and WM TECHNOLOGY, INC. (MAPS). Click either name above to swap in a different company.
Adaptive Biotechnologies Corp is the larger business by last-quarter revenue ($70.9M vs $43.1M, roughly 1.6× WM TECHNOLOGY, INC.). Adaptive Biotechnologies Corp runs the higher net margin — 4.7% vs -8.3%, a 13.0% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs -9.7%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs -1.5%).
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.
WM Entertainment is a South Korean entertainment company established in 2008 by former singer Lee Won-min. The company is responsible for managing artist Oh My Girl. On April 7, 2021, the company was acquired by RBW.
ADPT vs MAPS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.9M | $43.1M |
| Net Profit | $3.4M | $-3.6M |
| Gross Margin | 73.6% | 94.9% |
| Operating Margin | -27.1% | -13.5% |
| Net Margin | 4.7% | -8.3% |
| Revenue YoY | 35.1% | -9.7% |
| Net Profit YoY | — | -251.9% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $70.9M | — | ||
| Q4 25 | $71.7M | $43.1M | ||
| Q3 25 | $94.0M | $42.2M | ||
| Q2 25 | $58.9M | $44.8M | ||
| Q1 25 | $52.4M | $44.6M | ||
| Q4 24 | $47.5M | $47.7M | ||
| Q3 24 | $46.4M | $46.6M | ||
| Q2 24 | $43.2M | $45.9M |
| Q1 26 | $3.4M | — | ||
| Q4 25 | $-13.6M | $-3.6M | ||
| Q3 25 | $9.5M | $2.5M | ||
| Q2 25 | $-25.6M | $1.4M | ||
| Q1 25 | $-29.9M | $1.6M | ||
| Q4 24 | $-33.7M | $2.4M | ||
| Q3 24 | $-32.1M | $3.3M | ||
| Q2 24 | $-46.2M | $716.0K |
| Q1 26 | 73.6% | — | ||
| Q4 25 | 74.6% | 94.9% | ||
| Q3 25 | 80.7% | 95.0% | ||
| Q2 25 | 69.4% | 94.9% | ||
| Q1 25 | 67.6% | 95.0% | ||
| Q4 24 | 62.0% | 95.2% | ||
| Q3 24 | 64.1% | 95.3% | ||
| Q2 24 | 55.3% | 95.1% |
| Q1 26 | -27.1% | — | ||
| Q4 25 | -17.8% | -13.5% | ||
| Q3 25 | 10.9% | 4.6% | ||
| Q2 25 | -42.5% | 4.4% | ||
| Q1 25 | -56.4% | 5.9% | ||
| Q4 24 | -71.3% | 9.6% | ||
| Q3 24 | -70.3% | 11.2% | ||
| Q2 24 | -109.6% | 2.7% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | -18.9% | -8.3% | ||
| Q3 25 | 10.2% | 5.8% | ||
| Q2 25 | -43.5% | 3.2% | ||
| Q1 25 | -56.9% | 3.7% | ||
| Q4 24 | -71.0% | 4.9% | ||
| Q3 24 | -69.1% | 7.2% | ||
| Q2 24 | -107.0% | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.06 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.20 | $0.02 | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $-0.22 | — | ||
| Q2 24 | $-0.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.6M | $62.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $57.2M |
| Total Assets | $505.9M | $190.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $77.6M | — | ||
| Q4 25 | $70.5M | $62.4M | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | $43.2M | — | ||
| Q1 25 | $50.6M | — | ||
| Q4 24 | $47.9M | $52.0M | ||
| Q3 24 | $38.1M | — | ||
| Q2 24 | $59.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | $218.8M | $57.2M | ||
| Q3 25 | $204.4M | $56.9M | ||
| Q2 25 | $179.7M | $52.7M | ||
| Q1 25 | $190.4M | $48.5M | ||
| Q4 24 | $202.7M | $36.1M | ||
| Q3 24 | $223.8M | $29.5M | ||
| Q2 24 | $241.6M | $24.5M |
| Q1 26 | $505.9M | — | ||
| Q4 25 | $512.7M | $190.7M | ||
| Q3 25 | $490.6M | $192.9M | ||
| Q2 25 | $496.6M | $188.1M | ||
| Q1 25 | $510.9M | $183.8M | ||
| Q4 24 | $539.4M | $181.9M | ||
| Q3 24 | $558.5M | $173.6M | ||
| Q2 24 | $584.9M | $168.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $3.0M |
| Free Cash FlowOCF − Capex | — | $-280.0K |
| FCF MarginFCF / Revenue | — | -0.7% |
| Capex IntensityCapex / Revenue | — | 7.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.1M | $3.0M | ||
| Q3 25 | $-7.1M | $6.4M | ||
| Q2 25 | $-12.4M | $11.1M | ||
| Q1 25 | $-28.5M | $5.7M | ||
| Q4 24 | $-12.5M | $9.4M | ||
| Q3 24 | $-27.1M | $7.2M | ||
| Q2 24 | $-17.3M | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | $1.4M | $-280.0K | ||
| Q3 25 | $-7.5M | $3.6M | ||
| Q2 25 | $-13.1M | $8.2M | ||
| Q1 25 | $-29.7M | $2.0M | ||
| Q4 24 | $-12.6M | $7.3M | ||
| Q3 24 | $-27.4M | $4.9M | ||
| Q2 24 | $-19.0M | $10.1M |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | -0.7% | ||
| Q3 25 | -8.0% | 8.4% | ||
| Q2 25 | -22.2% | 18.3% | ||
| Q1 25 | -56.7% | 4.5% | ||
| Q4 24 | -26.5% | 15.2% | ||
| Q3 24 | -59.0% | 10.4% | ||
| Q2 24 | -44.1% | 21.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 7.7% | ||
| Q3 25 | 0.4% | 6.8% | ||
| Q2 25 | 1.1% | 6.3% | ||
| Q1 25 | 2.4% | 8.2% | ||
| Q4 24 | 0.2% | 4.5% | ||
| Q3 24 | 0.7% | 5.1% | ||
| Q2 24 | 4.0% | 5.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -0.75× | 2.61× | ||
| Q2 25 | — | 7.75× | ||
| Q1 25 | — | 3.44× | ||
| Q4 24 | — | 4.00× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | 17.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADPT
Segment breakdown not available.
MAPS
| Services | $39.5M | 92% |
| Other | $3.6M | 8% |
